Naama Kanarek, PhD

Naama Kanarek, PhD

“A simple dietary supplement to improve pediatric blood cancer therapy”

We propose to improve the use of methotrexate – the standard pediatric leukemia drug – with a simple dietary supplement. By enhancing methotrexate’s efficacy, and better monitoring patients’ responses to the drug, we aim to reduce the therapy’s long-term side effects and offer hope to young patients with a severe prognosis.